GLOW

Description

Overview

GLOW is a lyophilized multi-peptide research blend that combines three of the most widely studied regenerative-signalling molecules in the laboratory literature: GHK-Cu (copper tripeptide-1), BPC-157 (a stable gastric pentadecapeptide), and TB-500 (the full-length thymosin beta-4 sequence). It is supplied as a filler-free freeze-dried powder for in-vitro and preclinical research use only. GLOW is not a therapeutic product, and it is not intended for human or animal administration, diagnostic use, or any application involving living human subjects.

The blend is offered as a single-vial convenience format for laboratories that wish to co-investigate copper-dependent matrix signalling, cytoprotective pathways, and actin-based cell migration within one experimental system rather than reconstituting three separate reference materials.

Research Context

Each component of GLOW has an independent body of peer-reviewed preclinical literature, and researchers investigate the combination as a model for studying overlapping repair and remodelling pathways in cell culture and animal models.

• GHK-Cu is a naturally occurring copper-binding tripeptide first characterised by Pickart. In laboratory models it has been associated with collagen and elastin gene expression, glycosaminoglycan synthesis, and antioxidant signalling.
• BPC-157 is a synthetic sequence derived from a gastric protein fragment. Preclinical studies in rodent models have examined its relationship to tendon and soft-tissue outgrowth, fibroblast migration, and nitric-oxide-associated pathways.
• TB-500 (thymosin beta-4) is a 43-residue actin-sequestering peptide. In animal-model and in-vitro work it has been investigated for its role in angiogenesis, endothelial cell migration, and wound-bed re-epithelialisation.

Because the three peptides act on partially distinct but converging mechanisms, researchers use blends of this type to explore whether combined exposure produces additive or interacting effects on measurable endpoints such as fibroblast proliferation, capillary-tube formation, or scratch-assay closure rates.

Mechanism of Interest

The following mechanisms are described strictly as they appear in preclinical and in-vitro literature and do not constitute claims of efficacy in any living human context.

• Matrix and copper signalling: GHK-Cu is investigated as a modulator of extracellular-matrix remodelling genes and as a copper-delivery ligand relevant to redox-sensitive enzymes in cultured fibroblasts and keratinocytes.
• Cytoprotective and growth-factor pathways: BPC-157 is studied in relation to growth-factor receptor expression, VEGF-associated angiogenic signalling, and inflammatory cytokine balance in animal-model tissue.
• Actin sequestration and cell motility: TB-500 sequesters monomeric G-actin, a mechanism examined in the laboratory for its downstream effects on cell migration and vascular network formation.

Specifications

• Format: Lyophilized multi-peptide powder, filler-free
• Components: GHK-Cu, BPC-157, TB-500 (thymosin beta-4)
• Purity: Each peptide fraction characterised to 99%+ by HPLC (lot-specific values reported on the COA)
• Identity confirmation: Mass spectrometry per component
• Physical state: White to off-white lyophilised solid
• Grade: Research use only (RUO); not for human or veterinary use

Handling, Reconstitution & Storage

• Store the sealed lyophilised vial refrigerated at 2-8°C, or at -20°C for extended storage. Protect from light and moisture.
• For reconstitution in the laboratory, bacteriostatic or sterile water is typically introduced slowly against the vial wall; the vial is swirled rather than shaken to preserve peptide integrity. Copper-containing GHK-Cu solutions are generally protected from prolonged light exposure.
• Reconstituted solutions are commonly aliquoted and stored frozen to minimise freeze-thaw cycles; researchers should validate stability under their own conditions.
• All handling should follow standard laboratory practice, including appropriate PPE and documented chain-of-custody. This material is intended exclusively for qualified research personnel.

Quality & Verification

Every lot is accompanied by a third-party certificate of analysis (COA). The COA documents HPLC purity for each peptide fraction, mass-spectrometry identity confirmation, and appearance. G Peptide Labs is a Canadian research-peptide supplier, and orders ship domestically within Canada with cold-chain-appropriate packaging. Researchers are encouraged to cross-reference the lot number on the vial against the corresponding COA to confirm identity and purity before beginning experimental work.

Selected Research

Peer-reviewed references provided for scientific context; they describe laboratory and preclinical findings only.

1. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition Pickart L, 2008. PMID: 18644225
2. The potential of GHK as an anti-aging peptide. Aging Pathobiology and Therapeutics Dou Y, Lee A, Zhu L, Morton J, Ladiges W, 2020. PMID: 35083444
3. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH, 2011. PMID: 21030672
4. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mechanisms of Ageing and Development Philp D, Goldstein AL, Kleinman HK, 2004. PMID: 15037013